Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.720
+0.080 (4.88%)
Jun 29, 2026, 4:00 PM EDT - Market closed
Neumora Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $6 → $4 | Buy | Maintains | $6 → $4 | +132.56% | Jun 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 → $7 | Buy | Reiterates | $18 → $7 | +306.98% | Jun 16, 2026 |
| Needham | Needham | Buy Reiterates $8 → $5 | Buy | Reiterates | $8 → $5 | +190.70% | Jun 15, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 15, 2026 |
| J.P. Morgan | J.P. Morgan | Sell Maintains n/a | Sell | Maintains | n/a | n/a | May 27, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $3 | Hold | Maintains | $3 | +74.42% | May 12, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $14 | Buy | Maintains | $14 | +713.95% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $7 | Buy | Maintains | $7 | +306.98% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.